Qiagen N.V. (VIE:QGE3)

Austria flag Austria · Delayed Price · Currency is EUR
40.43
0.00 (0.00%)
At close: Dec 5, 2025
-5.60%
Market Cap 8.76B
Revenue (ttm) 1.76B
Net Income (ttm) 345.50M
Shares Out n/a
EPS (ttm) 1.57
PE Ratio 25.36
Forward PE 19.29
Dividend 1.42 (3.51%)
Ex-Dividend Date Jul 2, 2025
Volume n/a
Average Volume 5
Open 40.55
Previous Close 40.43
Day's Range 40.43 - 40.70
52-Week Range 35.38 - 47.34
Beta n/a
RSI 52.74
Earnings Date Feb 1, 2026

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and... [Read more]

Industry Laboratory Analytical Instruments
Founded 1984
Employees 5,396
Stock Exchange Vienna Stock Exchange
Ticker Symbol QGE3
Full Company Profile

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD Financial Statements

News

There is no news available yet.